120 related articles for article (PubMed ID: 12193561)
1. Potentiation of glucocorticoid receptor transcriptional activity by sumoylation.
Le Drean Y; Mincheneau N; Le Goff P; Michel D
Endocrinology; 2002 Sep; 143(9):3482-9. PubMed ID: 12193561
[TBL] [Abstract][Full Text] [Related]
2. Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor.
Tian S; Poukka H; Palvimo JJ; Jänne OA
Biochem J; 2002 Nov; 367(Pt 3):907-11. PubMed ID: 12144530
[TBL] [Abstract][Full Text] [Related]
3. SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.
Holmstrom SR; Chupreta S; So AY; Iñiguez-Lluhí JA
Mol Endocrinol; 2008 Sep; 22(9):2061-75. PubMed ID: 18562626
[TBL] [Abstract][Full Text] [Related]
4. Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor.
Tirard M; Almeida OF; Hutzler P; Melchior F; Michaelidis TM
Mol Cell Endocrinol; 2007 Mar; 268(1-2):20-9. PubMed ID: 17314004
[TBL] [Abstract][Full Text] [Related]
5. AF-2-dependent potentiation of CCAAT enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor.
Boruk M; Savory JG; Haché RJ
Mol Endocrinol; 1998 Nov; 12(11):1749-63. PubMed ID: 9817600
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
[TBL] [Abstract][Full Text] [Related]
7. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9.
Komatsu T; Mizusaki H; Mukai T; Ogawa H; Baba D; Shirakawa M; Hatakeyama S; Nakayama KI; Yamamoto H; Kikuchi A; Morohashi K
Mol Endocrinol; 2004 Oct; 18(10):2451-62. PubMed ID: 15192080
[TBL] [Abstract][Full Text] [Related]
8. Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy.
Holmstrom S; Van Antwerp ME; Iñiguez-Lluhi JA
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15758-63. PubMed ID: 14663148
[TBL] [Abstract][Full Text] [Related]
9. Analysis of glucocorticoid and androgen receptor gene fusions delineates domains required for transcriptional specificity.
Whitacre DC; Karnas KJ; Miesfeld RL
Endocrine; 2001 Jun; 15(1):111-8. PubMed ID: 11572317
[TBL] [Abstract][Full Text] [Related]
10. Expression level-dependent contribution of glucocorticoid receptor domains for functional interaction with STAT5.
Doppler W; Windegger M; Soratroi C; Tomasi J; Lechner J; Rusconi S; Cato AC; Almlöf T; Liden J; Okret S; Gustafsson JA; Richard-Foy H; Starr DB; Klocker H; Edwards D; Geymayer S
Mol Cell Biol; 2001 May; 21(9):3266-79. PubMed ID: 11287629
[TBL] [Abstract][Full Text] [Related]
11. Cross talk of signaling pathways in the regulation of the glucocorticoid receptor function.
Davies L; Karthikeyan N; Lynch JT; Sial EA; Gkourtsa A; Demonacos C; Krstic-Demonacos M
Mol Endocrinol; 2008 Jun; 22(6):1331-44. PubMed ID: 18337589
[TBL] [Abstract][Full Text] [Related]
12. Cooperative effects of STAT5 (signal transducer and activator of transcription 5) and C/EBPbeta (CCAAT/enhancer-binding protein-beta) on beta-casein gene transcription are mediated by the glucocorticoid receptor.
Wyszomierski SL; Rosen JM
Mol Endocrinol; 2001 Feb; 15(2):228-40. PubMed ID: 11158330
[TBL] [Abstract][Full Text] [Related]
13. RSUME enhances glucocorticoid receptor SUMOylation and transcriptional activity.
Druker J; Liberman AC; Antunica-Noguerol M; Gerez J; Paez-Pereda M; Rein T; Iñiguez-Lluhí JA; Holsboer F; Arzt E
Mol Cell Biol; 2013 Jun; 33(11):2116-27. PubMed ID: 23508108
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity.
Kang J; Gocke CB; Yu H
BMC Biochem; 2006 Feb; 7():5. PubMed ID: 16478538
[TBL] [Abstract][Full Text] [Related]
15. Molecular identification and characterization of a and b forms of the glucocorticoid receptor.
Yudt MR; Cidlowski JA
Mol Endocrinol; 2001 Jul; 15(7):1093-103. PubMed ID: 11435610
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid receptor/signal transducer and activator of transcription 5 (STAT5) interactions enhance STAT5 activation by prolonging STAT5 DNA binding and tyrosine phosphorylation.
Wyszomierski SL; Yeh J; Rosen JM
Mol Endocrinol; 1999 Feb; 13(2):330-43. PubMed ID: 9973262
[TBL] [Abstract][Full Text] [Related]
17. Repression of p65 transcriptional activation by the glucocorticoid receptor in the absence of receptor-coactivator interactions.
Wu J; Li Y; Dietz J; Lala DS
Mol Endocrinol; 2004 Jan; 18(1):53-62. PubMed ID: 14551261
[TBL] [Abstract][Full Text] [Related]
18. Sumoylation increases HIF-1alpha stability and its transcriptional activity.
Bae SH; Jeong JW; Park JA; Kim SH; Bae MK; Choi SJ; Kim KW
Biochem Biophys Res Commun; 2004 Nov; 324(1):394-400. PubMed ID: 15465032
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid receptor-DNA interactions: binding energetics are the primary determinant of sequence-specific transcriptional activity.
Bain DL; Yang Q; Connaghan KD; Robblee JP; Miura MT; Degala GD; Lambert JR; Maluf NK
J Mol Biol; 2012 Sep; 422(1):18-32. PubMed ID: 22698871
[TBL] [Abstract][Full Text] [Related]
20. Role for SUMO modification in facilitating transcriptional repression by BKLF.
Perdomo J; Verger A; Turner J; Crossley M
Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
